LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

LLY

1,130.08

+0.44%↑

JNJ

232.65

+1.91%↑

ABBV

227.34

+1.09%↑

UNH

400.31

+0.89%↑

MRK

120.93

+0.57%↑

Home・Список акций・Pacific Biosciences of California Inc

Pacific Biosciences of California Inc

Закрыт

СекторЗдравоохранение

1.44 -11.66

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1.3900000000000001

Макс.

1.44

Ключевые показатели
By Trading Economics
Доход	32M -8.3M
Продажи	-7.5M 37M
Прибыль на акцию	-0.12
Рентабельность продаж	-22.258
Сотрудники	485
EBITDA	509K -38M

Рекомендации
By TipRanks
Рекомендации	Нейтрально
Прогноз на 12 месяцев	+64.14% upside

Дивиденды
By Dow Jones
Следующий отчет о доходах	6 авг. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	9.5M 491M
Предыдущая цена открытия	13.1
Предыдущая цена закрытия	1.44

Новостные настроения

By Acuity

49%

51%

153 / 344 Рейтинг в Healthcare

Pacific Biosciences of California Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

5 июн. 2026 г., 19:20 UTC

Главные движущие силы рынка

Meta Platforms Slips on Report of Plans for Multibillion-Dollar Offering to Fund AI Buildout

5 июн. 2026 г., 21:27 UTC

Отчет

Carnage in Chip Stocks Hits Extra Hard in Top-Heavy Market -- WSJ

5 июн. 2026 г., 20:50 UTC

Обсуждения рынка

Tech, Media & Telecom Roundup: Market Talk

5 июн. 2026 г., 20:50 UTC

Обсуждения рынка

Financial Services Roundup: Market Talk

5 июн. 2026 г., 20:20 UTC

Приобретения, слияния, поглощения

Altice France Group Had Granted Initial Exclusivity Period to Consortium Until May 15, Which Was Then Extended to June 5

5 июн. 2026 г., 20:19 UTC

Приобретения, слияния, поглощения

Altice France Group, Bouygues Telecom, Free-iliad Group, Orange Exclusivity Period Extended by 48 Hours

5 июн. 2026 г., 20:15 UTC

Обсуждения рынка

Global Commodities Roundup: Market Talk

5 июн. 2026 г., 19:26 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

5 июн. 2026 г., 19:26 UTC

Обсуждения рынка

Hog Futures Tumble to Close Week -- Market Talk

5 июн. 2026 г., 19:10 UTC

Обсуждения рынка

Canada's GDP Targets From AI-Related Spending Require Second Look -- Market Talk

5 июн. 2026 г., 19:03 UTC

Обсуждения рынка

Oil Falls As Market Holds Out Hope for End to Conflict -- Market Talk

5 июн. 2026 г., 18:59 UTC

Обсуждения рынка

U.S. Natural-Gas Futures Pull Back After Gains -- Market Talk

5 июн. 2026 г., 18:47 UTC

Обсуждения рынка

Canada's Labor Market 'Retains Some Weakness' Despite Stellar May Report -- Market Talk

5 июн. 2026 г., 18:34 UTC

Обсуждения рынка

Hyperliquid ETFs Have Inflows Despite Crypto Weakness -- Market Talk

5 июн. 2026 г., 18:33 UTC

Приобретения, слияния, поглощения

The U.S. Government Could Take a Stake in OpenAI. What That Means for Tech Stocks. -- Barrons.com

5 июн. 2026 г., 17:50 UTC

Отчет

Lululemon Slumps on Earnings. Bargain Hunters Beware. -- Barrons.com

5 июн. 2026 г., 17:27 UTC

Обсуждения рынка

U.S. Oil Rig Count Rises for 6th Straight Week -- Market Talk

5 июн. 2026 г., 16:48 UTC

Приобретения, слияния, поглощения

Ryan Cohen Is Ready to Talk About eBay. For Real. -- Barrons.com

5 июн. 2026 г., 16:20 UTC

Обсуждения рынка

Tech, Media & Telecom Roundup: Market Talk

5 июн. 2026 г., 16:20 UTC

Обсуждения рынка

Financial Services Roundup: Market Talk

5 июн. 2026 г., 16:20 UTC

Обсуждения рынка

Health Care Roundup: Market Talk

5 июн. 2026 г., 16:15 UTC

Обсуждения рынка

Global Commodities Roundup: Market Talk

5 июн. 2026 г., 15:44 UTC

Приобретения, слияния, поглощения

Ryan Cohen Is Ready to Talk About eBay. For Real. -- Barrons.com

5 июн. 2026 г., 15:26 UTC

Обсуждения рынка

Gold Down Nearly 3% On Rate Hike Concerns After U.S. Hiring Data -- Market Talk

5 июн. 2026 г., 15:25 UTC

Отчет

Quantinuum Trades Below Offer Price. Why the Quantum Stock Is Sliding. -- Barrons.com

5 июн. 2026 г., 15:16 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

5 июн. 2026 г., 15:16 UTC

Обсуждения рынка

Zcash Tumbles After Exploit Found -- Market Talk

5 июн. 2026 г., 15:09 UTC

Обсуждения рынка

Canada's May Jobs Report Underscores Volatility Worries Over Data Collection -- Market Talk

5 июн. 2026 г., 15:07 UTC

Обсуждения рынка

Canada's Economy Still Has Legs With Total Employment Close to Record -- Market Talk

5 июн. 2026 г., 15:05 UTC

Обсуждения рынка

Canada's Labor-Market Weakness to Start 2026 Likely 'Overstated' -- Market Talk

Сравнение c конкурентами

Изменение цены

Pacific Biosciences of California Inc Прогноз

Целевая цена

By TipRanks

64.14% рост

Прогноз на 12 месяцев

Средняя 2.38 USD 64.14%

Максимум 3 USD

Минимум 1.5 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Pacific Biosciences of California Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

4 ratings

Покупка

Удержание

Продажа

Основано на мнении 4 аналитиков, присваивавших рейтинги акциям Pacific Biosciences of California Inc – Данные за последние 3 месяца.

Настроения

By Acuity

153 / 344Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.